On 8/14, MARX Biotech announced that the company will acquire ANB (安橋) with NT$30mn. ANB was established in 2022 as a spin-off from Bridge Drugstore, specializing in telemarketing to middle-aged consumers. This acquisition aims to strengthen MARX's ability in telemarketing and customer relationship management, enabling more precise marketing for its portfolio brands, enhancing customer loyalty and repurchase rate. The acquisition is expected to be completed by 8/31.